Substance Abuse Treatment, HIV/AIDS, and the Continuum of Response for People Who Inject Drugs
Open Access
- 29 November 2012
- journal article
- review article
- Published by Wiley in Advances in Preventive Medicine
- Vol. 2012, 1-8
Abstract
The continuum of response (CoR) to HIV/AIDS is a framework for implementation of HIV prevention, care, and treatment programs based on a national strategic plan for HIV/AIDS services. The CoR for people who inject drugs (PWID) is an important extension of the developed CoR to HIV/AIDS. The CoR-PWID employs stakeholders who together plan, develop, pilot, and provide a full range of services that address the various prevention, care/support, and treatment needs of people, families, and communities infected or affected by HIV/AIDS and injection drug use. The CoR-PWID comprises a broad range of services that include but are not limited to the World Health Organization priority interventions for HIV/AIDS prevention, treatment, and care in the health sector and the package of essential interventions for the prevention, treatment, and care of HIV for people who inject drugs. Implementation of these well-defined, essential prevention, care/support, and treatment services, in addition to locally defined needed services, in a coordinated fashion is important to clients, their families, and communities. The CoR-PWID is, therefore, a necessary framework essential for service development for countries that address HIV/AIDS in populations of PWID.Keywords
This publication has 34 references indexed in Scilit:
- Editorial Commentary: Viva No Difference!Clinical Infectious Diseases, 2012
- Improvement in the Health of HIV-Infected Persons in Care: Reducing DisparitiesClinical Infectious Diseases, 2012
- Assessment of Risky Injection Practices Associated with Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus and Using the Blood-Borne Virus Transmission Risk Assessment QuestionnaireJournal of Addictive Diseases, 2012
- Shooting up: the interface of microbial infections and drug abuseJournal of Medical Microbiology, 2011
- Fulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug usersNeurology, 2011
- Intramuscular extended‐release naltrexone: current evidenceAnnals of the New York Academy of Sciences, 2011
- Progress in HIV Reduction and Prevention Among Injection and Noninjection Drug UsersJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Use of Naltrexone to Treat Opioid Addiction in a Country in Which Methadone and Buprenorphine Are Not AvailableCurrent Psychiatry Reports, 2010
- Pharmacotherapy in the Treatment of Addiction: MethadoneJournal of Addictive Diseases, 2010
- Determinants of Health-Related Quality of Life of Opiate Users at Entry to Low-Threshold Methadone ProgramsEuropean Addiction Research, 2006